I asked ChatGPT for its top FTSE 100 stock for 2026, and it said…

Muhammad Cheema asked ChatGPT for its top FTSE 100 pick, and its response surprised him. He thinks he’s found an even better pick himself.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As the new year starts, investors are probably wondering what the best FTSE 100 stock to invest in is.

Last year, it was the mining company, Fresnillo, that was the darling of the index, after its 394.8% rise.

I turned to ChatGPT to see what it thought was the best company to invest in the Footsie for 2026. Surprisingly, it mentioned a stock I hadn’t even considered.

The stock in question is AstraZeneca (LSE:AZN). Let’s see below why I’m not so sure about the generative AI’s suggestion.

I’m not so sure…

While I think that AstraZeneca is a great company, it’s the reasons provided by ChatGPT that I’m not so sure about.

The first reason mentioned is the pharmaceutical giant’s strong share price performance of about 30% in 2025. The problem with this is that it is a very basic analysis and ignores the principle that just because a company has performed well in the past, it doesn’t mean it will in the future.

Furthermore, some of the other key reasons it mentioned don’t make sense to me. For example, it said the company has a valuation appeal. With a price-to-earnings (P/E) ratio of 30.9, I don’t believe its shares are valued cheaply at all. I think ChatGPT has it wrong here.

That said, there are things to like about the company. Notably, it has a strong pipeline of new pharmaceutical drugs that could drive up revenue and earnings if regulatory approval is granted.

However, because of valuation concerns and some other factors, such as the company having $24bn of net debt on its balance sheet, I don’t think it will turn out to be the best FTSE 100 stock for 2026.

A dirt-cheap alternative

My pick for 2026 is another mining stock, like Fresnillo. I think Rio Tinto (LSE:RIO) could be a great stock for investors to consider in the coming year.

With a P/E of only 13.1, it’s far cheaper than AstraZeneca. But what appeals to me the most is that it’s not priced like an AI stock, while being a potential big winner as the AI market continues growing.

How did I make this link with AI, you may be wondering right now?

Well, huge sums of money are anticipated to be spent on AI infrastructure over the next few years. For example, $3trn is expected to be spent on AI data centres through to 2029.

This presents a great opportunity for Rio Tinto, which is a key miner and producer of two of the key metals needed to make this happen: aluminium and copper.

Its Oyu Tolgoi mine in Mongolia hosts one of the world’s largest known copper deposits. This puts the miner in a strong competitive position.

There are risks with holding shares in the metal miner. For example, commodity price fluctuations could have a big impact on the company’s earnings, which could hurt its shares if there are adverse movements in metal prices.

Overall, though, I still think Rio Tinto shares are among the most compelling in the FTSE 100 over the coming year. Therefore, I think investors should consider its shares.

Muhammad Cheema has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc and Fresnillo Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 stocks to buy before they bounce back in 2026?

Buying undervalued stocks is a great way to try and build wealth. But it’s even better when the companies are…

Read more »

Mixed-race female couple enjoying themselves on a walk
Investing Articles

1 of the FTSE 100’s best bargains to consider for 2026!

Royston Wild discusses a top FTSE 100 share he owns in his portfolio -- and explains why he think it's…

Read more »

British Pennies on a Pound Note
Investing Articles

On a P/E ratio of just 3, is this penny stock a deep bargain?

Christopher Ruane previously made a profit buying and later selling this penny stock. Why has he bought it again, with…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

I’ve bought this 6.6%-yielding FTSE 250 share, hoping for a 2026 price recovery

This FTSE 250 share has more than halved in the past five years. But it still offers an attractive dividend…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

A once-in-a-decade chance to buy these UK income shares cheap?

The investing focus in 2026 might just be returning to long-term income shares after a roller-coaster decade for the UK…

Read more »

A GlaxoSmithKline scientist uses a microscope
Investing Articles

Up 9.9%! Here’s why Oxford Nanopore stock topped the FTSE 250 today

This innovative company's stock price marched higher today in the FTSE 250 index. Might this be my first Stocks and…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

Tesla stock’s defied gravity before. Can it do it again?

Could Tesla stock really be worth close to 300 times earnings -- or more? Christopher Ruane explains his thinking about…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

As Greggs’ share price dives, is this a once-in-a-decade opportunity?

The Greggs share price looks incredibly cheap on paper. But does this represent an attractive dip-buying opportunity? Royston Wild investigates.

Read more »